Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-alcoholic fatty liver disease and increased risk of all-cause mortality in elderly patients admitted for acute heart failure
Filippo Valbusa, Davide Agnoletti, Luca Scala, et al.
International Journal of Cardiology (2018) Vol. 265, pp. 162-168
Closed Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Complications, morbidity and mortality of nonalcoholic fatty liver disease
Alessandro Mantovani, Eleonora Scorletti, Antonella Mosca, et al.
Metabolism (2020) Vol. 111, pp. 154170-154170
Open Access | Times Cited: 443
Heart Failure and Liver Disease
Αndrew Xanthopoulos, Randall C. Starling, Takeshi Kitai, et al.
JACC Heart Failure (2018) Vol. 7, Iss. 2, pp. 87-97
Open Access | Times Cited: 239
Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications
Claudio Tana, Stefano Ballestri, Fabrizio Ricci, et al.
International Journal of Environmental Research and Public Health (2019) Vol. 16, Iss. 17, pp. 3104-3104
Open Access | Times Cited: 172
Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review
Luca Rinaldi, Pia Clara Pafundi, Raffaele Galiero, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 270-270
Open Access | Times Cited: 136
Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease
Alessandro Mantovani, Christopher D. Byrne, Giovanni Benfari, et al.
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 2, pp. 180-191
Open Access | Times Cited: 80
Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis
Yan Liu, Guo‐Chao Zhong, Hao-Yang Tan, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 136
Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact
Alfredo Caturano, Carlo Acierno, Riccardo Nevola, et al.
Processes (2021) Vol. 9, Iss. 1, pp. 135-135
Open Access | Times Cited: 79
Non‐alcoholic fatty liver disease‐related risk of cardiovascular disease and other cardiac complications
Christopher D. Byrne, Giovanni Targher
Diabetes Obesity and Metabolism (2021) Vol. 24, Iss. S2, pp. 28-43
Open Access | Times Cited: 78
Review article: non‐alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations
Stergios A. Pοlyzos, Stergios Kechagias, Emmanuel Tsochatzis
Alimentary Pharmacology & Therapeutics (2021) Vol. 54, Iss. 8, pp. 1013-1025
Open Access | Times Cited: 78
Mechanisms Linking Metabolic-Associated Fatty Liver Disease (MAFLD) to Cardiovascular Disease
Olufunto O. Badmus, Terry D. Hinds, David E. Stec
Current Hypertension Reports (2023) Vol. 25, Iss. 8, pp. 151-162
Open Access | Times Cited: 39
New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut–Liver–Heart Crosstalk
Keungmo Yang, Myeong Jun Song
Nutrients (2023) Vol. 15, Iss. 18, pp. 3970-3970
Open Access | Times Cited: 22
Comprehensive Review and Updates on Holistic Approach Towards Non-Alcoholic Fatty Liver Disease Management with Cardiovascular Disease
Nicholas Chew, Cheng Han Ng, Mark Muthiah, et al.
Current Atherosclerosis Reports (2022) Vol. 24, Iss. 7, pp. 515-532
Closed Access | Times Cited: 32
Nonalcoholic fatty liver disease and non-liver comorbidities
Richie Manikat, Mindie H. Nguyen
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. Suppl, pp. s86-s102
Open Access | Times Cited: 21
Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD)
Michael Johnston, Janisha Patel, Christopher D. Byrne
Current Pharmaceutical Design (2020) Vol. 26, Iss. 10, pp. 1079-1092
Open Access | Times Cited: 42
Extra-Hepatic Manifestations and Complications of Nonalcoholic Fatty Liver Disease
Stefano Ballestri, Alessandro Mantovani, Fabio Nascimbeni, et al.
Future Medicinal Chemistry (2019) Vol. 11, Iss. 16, pp. 2171-2192
Closed Access | Times Cited: 37
Comprehensive Review of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease
Kevan Josloff, Jacob Beiriger, Adnan Khan, et al.
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 12, pp. 419-419
Open Access | Times Cited: 20
Comparison of liver fibrosis scores for predicting mortality and morbidity in heart failure with preserved ejection fraction
Yalin Cao, Shuangqi Guo, Yugang Dong, et al.
ESC Heart Failure (2023) Vol. 10, Iss. 3, pp. 1771-1780
Open Access | Times Cited: 10
Liver stiffness as a cornerstone in heart disease risk assessment
Joost Boeckmans, Laurent Sandrin, Christian Knackstedt, et al.
Liver International (2023) Vol. 44, Iss. 2, pp. 344-356
Open Access | Times Cited: 9
Higher fatty liver index is associated with increased risk of new onset heart failure in healthy adults: a nationwide population-based study in Korea
Jae‐Hyung Roh, Jae‐Hyeong Park, Hanbyul Lee, et al.
BMC Cardiovascular Disorders (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 25
Cardiovascular Disease in Nonalcoholic Steatohepatitis: Screening and Management
Hersh Shroff, Lisa B. VanWagner
Current Hepatology Reports (2020) Vol. 19, Iss. 3, pp. 315-326
Open Access | Times Cited: 21
A New Non-Obese Steatohepatitis Mouse Model with Cardiac Dysfunction Induced by Addition of Ethanol to a High-Fat/High-Cholesterol Diet
Seiji Shiraishi, Jinyao Liu, Yuki Saito, et al.
Biology (2024) Vol. 13, Iss. 2, pp. 91-91
Open Access | Times Cited: 2
Nonalcoholic Fatty Liver Disease as a Potential Risk Factor for Cardiovascular Disease in Patients with Type 2 Diabetes: A Prospective Cohort Study
Mohammad Dehghani Firouzabadi, Amirhossein Poopak, Ali Sheikhy, et al.
International Journal of Endocrinology (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 2
Correlation of the Fatty Liver Index with the Pathophysiological Abnormalities Associated with Cardiovascular Risk Markers in Japanese Men without any History of Cardiovascular Disease: Comparison with the Fibrosis-4 Score
Yoichi Iwasaki, Kazuki Shiina, Chisa Matsumoto, et al.
Journal of Atherosclerosis and Thrombosis (2020) Vol. 28, Iss. 5, pp. 524-534
Open Access | Times Cited: 18
Weight loss breaks the bond between nonalcoholic fatty liver disease and cardiovascular diseases: A clinical and epidemiological perspective
Moein Ala, Seyed Parsa Eftekhar
Obesity Reviews (2023) Vol. 24, Iss. 6
Closed Access | Times Cited: 6
Non-alcoholic fatty liver disease is associated with a worse prognosis in patients with heart failure: A pool analysis
Min Qiu, Jiahuan Li, Shali Hao, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top